• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 3, 2022

    3/3/22 4:46:21 AM ET
    $ABUS
    $ACR
    $ADCT
    $ADTH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate
    Get the next $ABUS alert in real time by email

     

    Companies Reporting Before The Bell

    • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.

    • Urban One (NASDAQ:UONEK) is likely to report earnings for its fourth quarter.

    • Tile Shop Holdings (NASDAQ:TTSH) is likely to report earnings for its fourth quarter.

    • Oxford Square Capital (NASDAQ:OXSQ) is estimated to report quarterly earnings at $0.09 per share on revenue of $10.30 million.

    • Aurora Mobile (NASDAQ:JG) is projected to report quarterly loss at $0.07 per share on revenue of $15.65 million.

    • Mobile TeleSystems (NYSE:MBT) is estimated to report quarterly earnings at $0.19 per share on revenue of $1.69 billion.

    • LENSAR (NASDAQ:LNSR) is estimated to report quarterly loss at $0.52 per share on revenue of $8.70 million.

    • Bluegreen Vacations (NYSE:BVH) is likely to report quarterly earnings at $0.62 per share on revenue of $203.89 million.

    • Fulcrum Therapeutics (NASDAQ:FULC) is projected to report quarterly loss at $0.73 per share on revenue of $2.68 million.

    • EyePoint Pharmaceuticals (NASDAQ:EYPT) is expected to report quarterly loss at $0.53 per share on revenue of $9.80 million.

    • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.

    • Boqii Holding (NYSE:BQ) is projected to report quarterly loss at $0.09 per share on revenue of $59.45 million.

    • GlycoMimetics (NASDAQ:GLYC) is estimated to report earnings for its fourth quarter.

    • MINISO Group Holding (NYSE:MNSO) is likely to report quarterly earnings at $0.08 per share on revenue of $422.86 million.

    • Crescent Point Energy (NYSE:CPG) is expected to report quarterly earnings at $0.22 per share on revenue of $666.90 million.

    • Revlon (NYSE:REV) is likely to report quarterly earnings at $0.06 per share on revenue of $645.60 million.

    • Toro (NYSE:TTC) is estimated to report quarterly earnings at $0.62 per share on revenue of $967.83 million.

    • Antares Pharma (NASDAQ:ATRS) is projected to report quarterly earnings at $0.01 per share on revenue of $46.69 million.

    • Concert Pharmaceuticals (NASDAQ:CNCE) is projected to report quarterly loss at $0.73 per share on revenue of $20.00 thousand.

    • Weibo (NASDAQ:WB) is likely to report quarterly earnings at $0.81 per share on revenue of $607.75 million.

    • Burlington Stores (NYSE:BURL) is expected to report quarterly earnings at $3.25 per share on revenue of $2.78 billion.

    • BJ's Wholesale Club (NYSE:BJ) is likely to report quarterly earnings at $0.74 per share on revenue of $4.38 billion.

    • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $4.82 per share on revenue of $18.07 million.

    • Toronto-Dominion Bank (NYSE:TD) is projected to report quarterly earnings at $1.62 per share on revenue of $8.56 billion.

    • Best Buy Co (NYSE:BBY) is projected to report quarterly earnings at $2.73 per share on revenue of $16.59 billion.

    • Bilibili (NASDAQ:BILI) is projected to report quarterly loss at $0.68 per share on revenue of $913.86 million.

    • Kroger (NYSE:KR) is expected to report quarterly earnings at $0.74 per share on revenue of $32.86 billion.

    • Canadian Natural Res (NYSE:CNQ) is projected to report quarterly earnings at $1.65 per share on revenue of $6.82 billion.

    • Rain Therapeutics (NASDAQ:RAIN) is likely to report earnings for its fourth quarter.

    • HUTCHMED (China) (NASDAQ:HCM) is estimated to report earnings for its fourth quarter.

    • Fusion Fuel Green (NASDAQ:HTOO) is estimated to report earnings for its fourth quarter.

    • Via Renewables (NASDAQ:VIA) is likely to report earnings for its fourth quarter.

    • REE Automotive (NASDAQ:REE) is expected to report quarterly loss at $0.12 per share on revenue of $360.00 thousand.

    • Holley (NYSE:HLLY) is projected to report quarterly earnings at $0.12 per share on revenue of $148.58 million.

    • Utz Brands (NYSE:UTZ) is estimated to report quarterly earnings at $0.15 per share on revenue of $296.81 million.

    • ADC Therapeutics (NYSE:ADCT) is expected to report quarterly loss at $0.86 per share on revenue of $16.46 million.

    • Materialise (NASDAQ:MTLS) is estimated to report quarterly earnings at $0.04 per share on revenue of $59.74 million.

    • WAVE Life Sciences (NASDAQ:WVE) is likely to report quarterly loss at $0.51 per share on revenue of $15.79 million.

    • Sotherly Hotels (NASDAQ:SOHO) is estimated to report quarterly loss at $0.39 per share on revenue of $33.25 million.

    • Marcus (NYSE:MCS) is estimated to report quarterly loss at $0.18 per share on revenue of $154.31 million.

    • Brown Forman Inc Class B Common Stock (NYSE:BF) is estimated to report quarterly earnings at $0.47 per share on revenue of $983.13 million.

    • WhiteHorse Finance (NASDAQ:WHF) is likely to report quarterly earnings at $0.37 per share on revenue of $19.27 million.

    • Tecnoglass (NASDAQ:TGLS) is estimated to report quarterly earnings at $0.41 per share on revenue of $129.36 million.

    • Verona Pharma (NASDAQ:VRNA) is estimated to report earnings for its fourth quarter.

    • Stereotaxis (AMEX:STXS) is estimated to report quarterly loss at $0.05 per share on revenue of $7.73 million.

    • Methode Electronics (NYSE:MEI) is expected to report quarterly earnings at $0.72 per share on revenue of $281.60 million.

    • Altisource Portfolio (NASDAQ:ASPS) is projected to report quarterly loss at $0.77 per share on revenue of $39.56 million.

    • Gogo (NASDAQ:GOGO) is projected to report quarterly earnings at $0.08 per share on revenue of $89.67 million.

    • Superior Industries Intl (NYSE:SUP) is expected to report quarterly loss at $0.22 per share on revenue of $338.50 million.

    • Sprague Resources (NYSE:SRLP) is likely to report quarterly earnings at $0.34 per share on revenue of $968.22 million.

    • GMS (NYSE:GMS) is likely to report quarterly earnings at $1.74 per share on revenue of $1.13 billion.

    • CRA International (NASDAQ:CRAI) is expected to report quarterly earnings at $1.05 per share on revenue of $138.04 million.

    • Arbutus Biopharma (NASDAQ:ABUS) is likely to report quarterly loss at $0.19 per share on revenue of $2.87 million.

    • Big Lots (NYSE:BIG) is estimated to report quarterly earnings at $1.90 per share on revenue of $1.72 billion.

    • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.17 per share on revenue of $441.59 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly earnings at $0.04 per share on revenue of $318.84 million.

    • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.

    • Canaan (NASDAQ:CAN) is expected to report earnings for its fourth quarter.

    • Sibanye Stillwater (NYSE:SBSW) is expected to report earnings for its Fiscal Year 2021.

    • Grab Hldgs (NASDAQ:GRAB) is estimated to report earnings for its fourth quarter.

     

    Companies Reporting After The Bell

    • Payoneer Global (NASDAQ:PAYO) is estimated to report quarterly loss at $0.02 per share on revenue of $126.29 million.

    • VIZIO Holding (NYSE:VZIO) is likely to report quarterly loss at $0.18 per share on revenue of $699.36 million.

    • Ooma (NYSE:OOMA) is expected to report quarterly earnings at $0.10 per share on revenue of $49.97 million.

    • CPS Technologies (NASDAQ:CPSH) is expected to report earnings for its fourth quarter.

    • AdTheorent Holding (NASDAQ:ADTH) is likely to report quarterly earnings at $0.02 per share on revenue of $50.81 million.

    • Vicarious Surgical (NYSE:RBOT) is estimated to report earnings for its fourth quarter.

    • EzFill Holdings (NASDAQ:EZFL) is likely to report quarterly loss at $0.10 per share on revenue of $2.00 million.

    • PowerSchool Holdings (NYSE:PWSC) is projected to report quarterly earnings at $0.09 per share on revenue of $141.69 million.

    • Duolingo (NASDAQ:DUOL) is expected to report quarterly loss at $0.68 per share on revenue of $68.88 million.

    • DBV Technologies (NASDAQ:DBVT) is estimated to report quarterly loss at $0.54 per share on revenue of $2.21 million.

    • Treace Medical Concepts (NASDAQ:TMCI) is estimated to report earnings for its fourth quarter.

    • Agilon Health (NYSE:AGL) is expected to report quarterly loss at $0.11 per share on revenue of $452.89 million.

    • Intl General Insurance (NASDAQ:IGIC) is expected to report quarterly earnings at $0.23 per share on revenue of $148.90 million.

    • Entravision Comms (NYSE:EVC) is estimated to report quarterly earnings at $0.15 per share on revenue of $226.40 million.

    • Banco BBVA Argentina (NYSE:BBAR) is likely to report quarterly earnings at $0.21 per share on revenue of $236.94 million.

    • Trinity Capital (NASDAQ:TRIN) is expected to report quarterly earnings at $0.41 per share on revenue of $22.18 million.

    • PerkinElmer (NYSE:PKI) is expected to report quarterly earnings at $0.22 per share on revenue of $5.58 billion.

    • Montrose Environmental Gr (NYSE:MEG) is estimated to report quarterly earnings at $0.33 per share on revenue of $1.18 billion.

    • Grid Dynamics Holdings (NASDAQ:GDYN) is likely to report quarterly earnings at $0.08 per share on revenue of $58.55 million.

    • Algonquin Power (NYSE:AQN) is expected to report quarterly earnings at $0.28 per share on revenue of $690.81 million.

    • Invesco DWA Industrials Momentum ETF (NASDAQ:PRN) is estimated to report quarterly loss at $0.42 per share on revenue of $3.25 million.

    • Atreca (NASDAQ:BCEL) is projected to report earnings for its fourth quarter.

    • Gossamer Bio (NASDAQ:GOSS) is likely to report earnings for its fourth quarter.

    • Puma Biotechnology (NASDAQ:PBYI) is likely to report quarterly loss at $0.09 per share on revenue of $47.17 million.

    • Fidus Investment (NASDAQ:FDUS) is expected to report quarterly earnings at $0.36 per share on revenue of $20.53 million.

    • Funko (NASDAQ:FNKO) is estimated to report quarterly earnings at $0.24 per share on revenue of $272.49 million.

    • AeroVironment (NASDAQ:AVAV) is expected to report quarterly earnings at $0.30 per share on revenue of $106.72 million.

    • Cellectis (NASDAQ:CLLS) is likely to report quarterly loss at $0.92 per share on revenue of $8.72 million.

    • Calyxt (NASDAQ:CLXT) is likely to report quarterly loss at $0.41 per share on revenue of $2.64 million.

    • Great Ajax (NYSE:AJX) is projected to report quarterly earnings at $0.38 per share on revenue of $20.51 million.

    • Gap (NYSE:GPS) is expected to report quarterly loss at $0.14 per share on revenue of $4.49 billion.

    • Costco Wholesale (NASDAQ:COST) is projected to report quarterly earnings at $2.73 per share on revenue of $51.37 billion.

    • SIGA Technologies (NASDAQ:SIGA) is estimated to report earnings for its fourth quarter.

    • Smith & Wesson Brands (NASDAQ:SWBI) is likely to report quarterly earnings at $0.86 per share on revenue of $198.29 million.

    • Sweetgreen (NYSE:SG) is likely to report quarterly loss at $0.66 per share on revenue of $84.71 million.

    • Cvent Holding (NASDAQ:CVT) is projected to report quarterly earnings at $0.02 per share on revenue of $140.72 million.

    • Arteris (NASDAQ:AIP) is estimated to report quarterly loss at $0.17 per share on revenue of $10.70 million.

    • Runway Growth Finance (NASDAQ:RWAY) is likely to report quarterly earnings at $0.26 per share on revenue of $18.12 million.

    • Xponential Fitness (NYSE:XPOF) is likely to report quarterly loss at $0.14 per share on revenue of $42.03 million.

    • Integral Ad Science (NASDAQ:IAS) is likely to report quarterly loss at $0.01 per share on revenue of $94.83 million.

    • Enovix (NASDAQ:ENVX) is estimated to report quarterly loss at $0.15 per share on revenue of $750.00 thousand.

    • Alignment Healthcare (NASDAQ:ALHC) is estimated to report quarterly loss at $0.30 per share on revenue of $269.57 million.

    • Evolus (NASDAQ:EOLS) is estimated to report quarterly loss at $0.19 per share on revenue of $33.99 million.

    • Chembio Diagnostics (NASDAQ:CEMI) is projected to report quarterly loss at $0.20 per share on revenue of $13.55 million.

    • National CineMedia (NASDAQ:NCMI) is projected to report quarterly loss at $0.04 per share on revenue of $67.80 million.

    • Oncolytics Biotech (NASDAQ:ONCY) is expected to report earnings for its fourth quarter.

    • Veritone (NASDAQ:VERI) is estimated to report quarterly earnings at $0.20 per share on revenue of $44.80 million.

    • Salem Media Group (NASDAQ:SALM) is projected to report quarterly earnings at $0.06 per share on revenue of $66.59 million.

    • Issuer Direct (AMEX:ISDR) is likely to report earnings for its fourth quarter.

    • INmune Bio (NASDAQ:INMB) is expected to report earnings for its fourth quarter.

    • First Eagle Alternative (NASDAQ:FCRD) is expected to report quarterly earnings at $0.10 per share on revenue of $8.43 million.

    • Eagle Bulk Shipping (NASDAQ:EGLE) is expected to report quarterly earnings at $6.00 per share on revenue of $152.12 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report quarterly earnings at $0.18 per share on revenue of $277.96 million.

    • ACRES Commercial Realty (NYSE:ACR) is projected to report quarterly earnings at $0.14 per share on revenue of $11.90 million.

    • Profound Medical (NASDAQ:PROF) is projected to report quarterly loss at $0.37 per share on revenue of $3.00 million.

    • FedNat Holding (NASDAQ:FNHC) is projected to report quarterly loss at $1.02 per share on revenue of $69.59 million.

    • Aziyo Biologics (NASDAQ:AZYO) is expected to report quarterly loss at $0.68 per share on revenue of $11.06 million.

    • Elastic (NYSE:ESTC) is expected to report quarterly loss at $0.21 per share on revenue of $209.36 million.

    • Quanex Building Prods (NYSE:NX) is projected to report quarterly earnings at $0.26 per share on revenue of $242.89 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report earnings for its fourth quarter.

    • Cooper Companies (NYSE:COO) is estimated to report quarterly earnings at $3.10 per share on revenue of $744.34 million.

    • Marvell Technology (NASDAQ:MRVL) is estimated to report quarterly earnings at $0.48 per share on revenue of $1.32 billion.

    • Broadcom (NASDAQ:AVGO) is likely to report quarterly earnings at $8.08 per share on revenue of $7.60 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABUS
    $ACR
    $ADCT
    $ADTH

    CompanyDatePrice TargetRatingAnalyst
    Passage Bio Inc.
    $PASG
    2/10/2026$21.00Buy
    Chardan Capital Markets
    Wave Life Sciences Ltd.
    $WVE
    2/5/2026$38.00Buy
    BofA Securities
    The Cooper Companies Inc.
    $COO
    2/3/2026$100.00 → $99.00Buy
    Needham
    Best Buy Co. Inc.
    $BBY
    2/2/2026$76.00Overweight → Neutral
    Analyst
    Broadcom Inc.
    $AVGO
    1/30/2026$400.00Peer Perform → Outperform
    Wolfe Research
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/23/2026$100.00Buy → Hold
    Melius
    More analyst ratings

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Human Resources Officer Wagner Andreas P. sold $455,212 worth of shares (22,238 units at $20.47), decreasing direct ownership by 12% to 169,805 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/10/26 9:51:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Chief Executive Officer Kao John E sold $3,687,354 worth of shares (180,000 units at $20.49) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/10/26 9:50:30 PM ET
    $ALHC
    Medical Specialities
    Health Care

    CHIEF OPERATING OFFICER Gryzlov Yury was granted 98,736 shares and covered exercise/tax liability with 25,964 shares, increasing direct ownership by 15% to 547,308 units (SEC Form 4)

    4 - GRID DYNAMICS HOLDINGS, INC. (0001743725) (Issuer)

    2/10/26 9:17:52 PM ET
    $GDYN
    Computer Software: Prepackaged Software
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TESTOSTERONE UNDECANOATE issued to ANTARES PHARMA INC

    Submission status for ANTARES PHARMA INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Approval' on 03/28/2022. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

    3/30/22 12:07:58 PM ET
    $ATRS
    Medical/Dental Instruments
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marvell Completes Acquisition of XConn Technologies

    Marvell Technology, Inc. (NASDAQ:MRVL), a leader in data infrastructure semiconductor solutions, today announced that it has completed its previously announced acquisition of XConn Technologies ("XConn"), a provider of advanced PCIe and CXL switching silicon. The acquisition expands Marvell's switching portfolio with XConn's PCIe and CXL products and strengthens Marvell's capabilities in scale-up connectivity for next-generation AI and cloud data center architectures. XConn's engineering team and technology will play a key role in advancing Marvell's UALink scale-up switching roadmap as AI systems evolve toward larger, multi-rack deployments. Expected Financial Impact Marvell expect

    2/10/26 5:25:00 PM ET
    $MRVL
    Semiconductors
    Technology

    DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting

    Châtillon, France, February 10, 2026 DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting DBV Technologies (TRQX:DBVp), a late-stage biopharmaceutical company, today announced that the company will present additional data for the VIASKIN® Peanut Patch in children ages 4-7 years from the positive VITESSE Phase 3 study at the American Academy of Allergy, Asthma, and Immunology 2026 Annual Meeting, taking place in Philadelphia, PA February 27-March 2, 2026. The Company will also host a product theatre featuring a panel of renowned a

    2/10/26 4:30:00 PM ET
    $DBVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Skip the Reservation: Kroger Makes Valentine's Day Special with Surf and Turf Savings

    Retailer shares expert meat and seafood tips, special offers for date night at home CINCINNATI, Feb. 10, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its bringing date night home with a romantic and delicious Surf and Turf dinner, perfect for lovebirds to celebrate Valentine's Day without the hassle of a reservation. Customers can also get special gifts delivered straight to their loved ones' doors with DoorDash and Uber Eats. "Quality ingredients are the foundation of any romantic dinner and Kroger consistently delivers on quality and affordability," said Car

    2/10/26 1:00:00 PM ET
    $KR
    Food Chains
    Consumer Staples

    $ABUS
    $ACR
    $ADCT
    $ADTH
    SEC Filings

    View All

    SEC Form S-8 filed by Marvell Technology Inc.

    S-8 - Marvell Technology, Inc. (0001835632) (Filer)

    2/10/26 5:29:40 PM ET
    $MRVL
    Semiconductors
    Technology

    SEC Form 424B3 filed by Toronto Dominion Bank

    424B3 - TORONTO DOMINION BANK (0000947263) (Filer)

    2/10/26 2:36:37 PM ET
    $TD
    Commercial Banks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by BJ's Wholesale Club Holdings Inc.

    SCHEDULE 13G/A - BJ's Wholesale Club Holdings, Inc. (0001531152) (Subject)

    2/10/26 1:47:52 PM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wulf John William bought $50,941 worth of shares (81,000 units at $0.63), increasing direct ownership by 28% to 365,857 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    1/30/26 7:30:58 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    Director Seizinger Bernd R. bought $103,770 worth of shares (100,000 units at $1.04), increasing direct ownership by 27% to 466,991 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    1/20/26 4:30:18 PM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, Chief Legal Officer Shea Theresa Robbins bought $6,922 worth of shares (702 units at $9.86), covered exercise/tax liability with 11,890 shares and was granted 43,414 shares, increasing direct ownership by 59% to 87,191 units (SEC Form 4)

    4 - Utz Brands, Inc. (0001739566) (Issuer)

    1/6/26 4:50:24 PM ET
    $UTZ
    Packaged Foods
    Consumer Staples

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chardan Capital Markets resumed coverage on Passage BIO with a new price target

    Chardan Capital Markets resumed coverage of Passage BIO with a rating of Buy and set a new price target of $21.00

    2/10/26 6:56:48 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BofA Securities initiated coverage on Wave Life Sciences with a new price target

    BofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00

    2/5/26 9:31:24 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Needham reiterated coverage on Cooper with a new price target

    Needham reiterated coverage of Cooper with a rating of Buy and set a new price target of $99.00 from $100.00 previously

    2/3/26 7:02:57 AM ET
    $COO
    Ophthalmic Goods
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Leadership Updates

    Live Leadership Updates

    View All

    Kroger Appoints Greg Foran as Chief Executive Officer

    Accomplished Food Retail Leader Brings Strong Experience as Company Advances Its Growth Strategy Ron Sargent Continues as Chairman of Kroger's Board of Directors  CINCINNATI, Feb. 9, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its Board of Directors appointed Greg Foran as Chief Executive Officer, effective immediately. Foran will also join Kroger's Board of Directors and succeeds Ron Sargent, who served as interim CEO since March 2025. This announcement follows an extensive search process conducted by the Board to identify an innovative retail leader with a strong track record of execution at scale.

    2/9/26 7:30:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    FirstEnergy's Pennsylvania Default Service Program DSP-VI Auctions: Information Session for Prospective Bidders on Wednesday, February 4, 2026

    CRA International, Inc. (NASDAQ:CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that an auction process will be conducted for FirstEnergy Pennsylvania Electric Company (FE PA) to procure full requirements Default Supply generation service for their Default Service Customers. The auction process will lead up to the auctions scheduled for April 7, 2026. The bidding process will use a descending-price clock auction format. The auctions will be managed by Independent Evaluator and Auction Manager, CRA International, Inc. The auctions are being conducted pursuant to FirstEnergy's Pennsylvania Default Service Program (DSP-VI) as ap

    2/3/26 8:30:00 AM ET
    $CRAI
    Other Consumer Services
    Consumer Discretionary

    Crawford & Company® Announces New Operating Divisions

    Appoints Michael Hoberman CEO of U.S. Operations Crawford & Company® (NYSE:CRD) has announced a new global operating structure designed to accelerate its client-centric strategy to deliver an integrated service model, strengthen collaboration across geographies and enhance the company's ability to deliver unmatched service to clients worldwide. Effective January 1, 2026, Crawford will operate under two divisions – U.S. Operations and International Operations – reflecting a simplified, more client-centric model built for speed, accountability and market responsiveness. Under the new structure, Mike Hoberman has been promoted to CEO of U.S. Operations, reporting to interim Crawford Pres

    1/21/26 4:15:00 PM ET
    $CRD

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Financials

    Live finance-specific insights

    View All

    Runway Growth Finance Corp. Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    MENLO PARK, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. ("Runway Growth" or the "Company") (NASDAQ:RWAY), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET). To participate in the conference call or webcast, participants should register online at the Runway Growth Investor Relations website. Participants are requested to register a day in adv

    2/10/26 8:30:00 AM ET
    $RWAY
    Finance: Consumer Services
    Finance

    Travelzoo Q4 2025 Earnings Conference Call on February 19 at 11:00 AM ET

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO): WHAT: Travelzoo, the club for travel enthusiasts, will host a conference call to discuss the Company's financial results for the fourth quarter ended December 31, 2025. Travelzoo will issue a press release reporting its results before the market opens on February 19, 2026. WHEN: February 19, 2026 at 11:00 AM ET HOW: A live webcast of Travelzoo's Q4 2025 earnings conference call can be accessed at http://ir.travelzoo.com/events-presentations. The webcast will be archived within 2 hours of the end of the call and

    2/9/26 12:29:00 PM ET
    $TZOO
    Advertising
    Consumer Discretionary

    Marvell Technology, Inc. Announces Conference Call to Review Fourth Fiscal Quarter and Fiscal Year 2026 Financial Results

    Marvell Technology, Inc. (NASDAQ:MRVL), a leader in data infrastructure semiconductor solutions, today announced it will conduct a conference call following the release of its fourth fiscal quarter and fiscal year 2026 financial results on Thursday, March 5, 2026, at 1:45 p.m. Pacific Time. Conference Call Interested parties may join the live conference call without operator assistance at Call me™ (link will be active approximately 30 minutes before the call) to receive an instant automated callback. To join the call with operator assistance, please dial 1-877-407-8291 or 1-201-689-8345. The call will be webcast and can be accessed at the Marvell Investor Relations website at http://inv

    2/9/26 9:00:00 AM ET
    $MRVL
    Semiconductors
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Sotherly Hotels Inc.

    SC 13G - Sotherly Hotels Inc. (0001301236) (Subject)

    12/9/24 11:56:15 AM ET
    $SOHO
    Real Estate Investment Trusts
    Real Estate

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care